Navigation Links
New Power Of Personalized Medicine For Baby Described At March Of Dimes Luncheon
Date:12/11/2013

WHITE PLAINS, N.Y., Dec. 11, 2013 /PRNewswire-USNewswire/ -- The ability to analyze a hospitalized newborn's genome within hours rather than weeks is helping doctors diagnose babies' illnesses and provide treatment that is individualized to an infant's specific genetic makeup and metabolism.

(Logo: http://photos.prnewswire.com/prnh/20130214/DC59689LOGO)

Two experts in the field of genomics will discuss personalized medicine for newborns at a luncheon today for reporters sponsored by the March of Dimes. They will explain how personalized medicine can and is being used in neonatal intensive care units (NICUs) and its potential to change how newborns are treated.

Dr. Stephen Kingsmore, director of the Center for Pediatric Genomic Medicine at Children's Mercy Hospital in Kansas City, Missouri, will discuss his research that allows for inexpensive, targeted genome sequencing for babies to be completed in hours, compared to the weeks it previously took. His findings helps end parents' medical odyssey for a diagnosis, and guides treatment decisions. Dr. Bruce Carleton, professor in the University of British Columbia's pediatrics department and director of the Pharmaceutical Outcomes Programme at British Columbia's Children's Hospital in Vancouver, Canada, will present his research on how targeted genome sequencing can be used to prevent bad or unwanted reactions to medications by identifying sequence variations that predispose the individual to these outcomes.

The Human Genome Project, which in 2003 identified nearly all of the genes in human DNA, offered the promise of personalized genomic medicine. Genome sequencing – decoding and providing a detailed description of the order of the nucleotides (chemical building blocks) of an individual's DNA – can be a powerful tool for diagnosing rare and common genetic disorders, the speakers said. Not only can genome sequencing help guide treatment decisions and allow for preventative measures to be taken earlier than ever before, it can actually change treatment and help health care providers better manage a condition.

"Genetic diseases result from a mistake in the DNA code," says Dr. Kingsmore. "Identifying those mistakes in the vastness of the genome is difficult. But once you have a genetic diagnosis, the focus can shift to treatments that target the underpinning mechanism and outcomes. Our work helps get to that point in days."

"Most drug research focuses on adults, and rarely does one investigate the adverse drug reactions a medication might have on a newborn," says Dr. Carleton. "Targeted genome sequencing will let us know which babies will be harmed rather than helped by a drug treatment."

In 2013, the March of Dimes celebrated its 75th Anniversary and its ongoing work to help babies get a healthy start in life. About 4 million babies are born each year in the United States, and all have benefitted the March of Dimes life saving research and education.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit marchofdimes.com or nacersano.org. Find us on Facebook and follow us on Twitter.


'/>"/>
SOURCE March of Dimes
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference
2. ResearchMoz: Global Power Wheelchairs Market Will Reach $3.9 Billion by 2018 - Market Research Report
3. Effectiveness of Medicare Authorization Program for Power Wheelchairs Rests on Inclusion of a Clinical Template
4. The Healing Power of Human Milk
5. Kaiser Permanente Ranks Highest in 2012 J.D. Power and Associates Employer Satisfaction Study for Second Year in a Row
6. Providers of Durable Medical Equipment Ensure Independence and Safety during Extreme Weather and Power Outages
7. Physician Details Problems with Medicare Approval Process for Power Wheelchairs
8. Power Wheelchair Brings Independence and Hope to Man with Complications Due to Spina Bifida
9. American Association for Homecare Expects Medicare to Move Past its Deny-at-All-Costs Culture that Routinely Denies Claims for Power Wheelchairs
10. The Princess Margaret BMT Program Chooses Remedy Informatics Blood and Marrow Transplant & Cell Therapy Solutions to Power their fight Against Cancer
11. Henry Schein Announces Featured Speakers For The "Recovery Empowerment Symposium: Emerging From The Storm"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):